# Study on Pharmacokinetics of Hydronidone

> **NCT04162821** · PHASE1 · COMPLETED · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Pharmacokinetics of Hydronidone

## Interventions

- **DRUG:** Hydronidone

## Key facts

- **NCT ID:** NCT04162821
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2019-11-27
- **Final completion:** 2021-03-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04162821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04162821, "Study on Pharmacokinetics of Hydronidone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04162821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*